97028 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Receptors; Cell surface antigens; Cell surface determinants
Anti human Notch4 antibody
#1802Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#1803Methods of treating cardiovascular disease with an ASGR inhibitor
#1804Mesothelin-targeted chimeric antigen receptors and uses thereof
#1805Fusion protein inhibiting TACI-BAFF complex formation and preparation method therefor and use thereof
#1806Targeted delivery of glycine receptors to excitable cells
#1807Optically-based stimulation of target cells and modifications thereto
#1808Sfrp5-derived peptide fragment and cosmetic composition for skin whitening containing same
#1809Xenoantigen-displaying anti-cancer vaccines and method of making
#1810ASSAY-READY RECOMBINANT CELLS TRANSIENTLY OVEREXPRESSING GENES ENCODING DRUG TRANSPORTER PROTEINS AND/OR DRUG METABOLIZING ENZYMES
#1811Antibodies specific for sulfation sites of sclerostin
#1812Stitched polypeptides
#1813Device for mooring a water craft to a mooring berth of a pontoon, and corresponding pontoon
#1814Method and biomarker for detecting metastasis of sarcoma
#1815Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist
#1816APLNR modulators and uses thereof
#1817Variants derived from ActRIIB and uses therefor
#1818Pharmaceuticals in joint-linker configurations for treating pathological blood clots
#1819Peptides of syndecan-1 for inhibiting angiogenesis
#1820Optically-based stimulation of target cells and modifications thereto
#1821Vesicular stomatitis viruses
#1822Compositions and methods of chimeric autoantibody receptor T cells
#1823Enhanced AAV-mediated gene transfer for retinal therapies
#1824Methods for off-the-shelf-tumor immunotherapy using allogeneic T-cell precursors
#1825MUTANT SMOOTHENED AND METHODS OF USING THE SAME
#1826EXPRESSION OF TRIPLE-HELICAL COLLAGEN-LIKE PRODUCTS IN E.COLI
#1827TREATMENT OF COMPLEMENT-ASSOCIATED DISORDERS
#1828Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1829Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1830Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1831Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers
#1832Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1833Method for treating cancer with an activated T lymphocyte that selectively recognizes a cancer cell consisting of specific peptide
#1834Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1835Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1836Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1837Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#1838Muller cell-specific promoter
#1839Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor
#1840Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
#1841Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
#1842Human biosensors for detecting voltage changes
#1843Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof
#1844Chimeric antigen receptor (CAR) signalling system
#1845SorCS1 for the treatment of obesity
#1846Human biosensors for detecting ATP
#1847Transformant for expressing cis-prenyltranferase and Nogo B receptor
#1848Mimetic peptides which modulate L-type calcium channels
#1849Peptide vaccine therapy for treatment of FRα-expressing tumors
#1850Protein markers associated bone marrow stem cell differentiation into early progentior cells
#1851Compositions and methods for treating cancer
#1852Cold- and menthol-sensitive receptor (CMR1)
#1853EphA2 T-cell epitope agonists and uses therefore
#1854Peptides and methods and uses thereof for preventing retinal disorders
#1855Brown adipocyte modification
#1856TRPC6 involved in glomerulonephritis
#1857Diagnosis and therapy of multiple sclerosis
#1858Heat-sensing protein switches and uses thereof
#1859Methods and compositions for the inhibition of TRPV4
#1860TENEURIN C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF
#1861Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof
#1862Methods and Compositions for Detecting Botulinum Neurotoxin
#1863Organic compounds
#1864Recombinant factor VIII proteins
#1865Diagnosis of a neuroautoimmune disease comprising measuring autoantibodies to flotillin1 and/or flotillin2
#1866AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells
#1867Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of Lingo-1 Antagonists and TrkB Agonists
#1868Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof
#1869Sperm-Specific Cation Channel, Catsper3, and Uses Therefor
#1870SPERM-SPECIFIC CATION CHANNEL, CATSPER4, AND USES THEREFOR
#1871Anti human Notch4 antibody
#1872Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#1873Peptide mimotopes of claudin 18.2 and uses thereof
#1874VSTM5 POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF CANCER, INFECTIOUS DISEASES AND IMMUNE RELATED DISEASES
#1875Compositions and methods to modulate cell activity
#1876Immunotherapy with binding agents
#1877FKBP-L polypeptides and uses in angiogenesis-mediated disorders
#1878FKBP-L AND USES THEREOF
#1879Tumor necrosis factor (TNF) family ligand trimer-containing antigen binding molecules
#1880Class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type I receptor (IGF-1R)
#1881Biological Pacemakers Incorporating HCN2 and SkM1 Genes
#1882Pro-angiogenic peptides and peptide conjugates
#1883System and method for controlling G-protein coupled receptor pathways
#1884Treatment of ocular disorders with anti-connexin proteins and mimetics
#1885Methods for screening for binding partners of G-protein coupled receptors
#1886USE OF CRISPR/CAS9 AS IN VIVO GENE THERAPY TO GENERATE TARGETED GENOMIC DISRUPTIONS IN GENES BEARING DOMINANT MUTATIONS FOR RETINITIS PIGMENTOSA
#1887NOVEL FUSION GENES AS FACTORS RESPONSIBLE FOR GASTRIC CANCER
#1888MET-BINDING AGENTS AND USES THEREOF
#1889Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulin
#1890Method of loading a crystallization device
#1891Etanercept formulations stabilized with xylitol
#1892Pharmaceutical compositions targeting WNT pathway proteins
#1893Mutant smoothened and methods of using the same
#1894Methods of identifying modulators of olfactory receptors
#1895Plexin D1 as a target for tumor diagnosis and therapy
#1896Peptide and application thereof
#1897SYSTEMS AND METHODS FOR CONTROLLING ANIMAL BEHAVIOR VIA OPTOGENETICS
#1898TUMOR ANTIGEN PEPTIDE
#1899CELL LINES AND METHODS FOR MAKING AND USING THEM
#1900Peptide substrates recognizable by type E botulinum neurotoxin
#1901Directed evolution and in vivo panning of virus vectors
#1902GLYCOSYLATED GLYCOPHORIN PEPTIDES
#1903PAR4 agonist peptides
#1904Optically-controlled CNS dysfunction
#1905Animal model and method for studying gene-gene interactions
#1906EPHA3 And multi-valent targeting of tumors
#1907MEANS AND METHODS FOR DETERMINATION OF BOTULINUM NEUROTOXIN BIOLOGICAL ACTIVITY
#1908Antibodies that specifcally bind Sost and Wise peptides
#1909Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#1910ALK4:ActRIIB heteromultimers and uses thereof
#1911Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#1912Anti-PD-1 antibody and use thereof
#1913Method for identifying modulators of notch signaling
#1914Protease-resistant systems for polypeptide display and methods of making and using thereof
#1915Binding-triggered transcriptional switches and methods of use thereof
#1916Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)
#1917Water soluble membrane proteins and methods for the preparation and use thereof
#1918Environmentally sensitive compositions and methods of use thereof
#1919Muteins of tear lipocalin and methods for obtaining the same
#1920Light-activated cation channel and uses thereof
#1921Polynucleotides encoding low density lipoprotein receptor
#1922Na1.7 antibodies and methods of using the same
#1923NOVEL CELL LINES EXPRESSING ENaC and METHODS USING THEM
#1924METHODS OF TREATING NEUROENDOCRINE TUMORS USING FRIZZLED-BINDING AGENTS
#1925Vectors for expression of prostate-associated antigens
#1926Nanovesicle comprising heterodimeric G-protein coupled receptor, method for preparing nanovesicle, field effect transistor-based taste sensor comprising nanovesicle, and method for manufacturing taste sensor
#1927Compositions and methods for detecting and treating neurological conditions
#1928Cyclic peptide conjugates and methods of use
#1929Photoreactive synthetic regulator of protein function and methods of use thereof
#1930Sonogenic stimulation of cells
#1931IL-18 binding protein (IL-18BP) in inflammatory diseases
#1932Soluble CD33 for treating myelodysplastic syndromes (MDS)
#1933STING crystals and modulators
#1934Methods for increasing palatability of pet foodstuff
#1935Anti-human folate receptor beta antibodies and methods of use
#1936Molecular constructs for treating tumors
#1937Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#1938LRP-8 binding dual variable domain immunoglobulin proteins
#1939Etanercept formulations stabilized with combinations of sugars and polyols
#1940Anti-P2Xpeptides and epitopes
#1941Identification of tumor-associated cell surface antigens for diagnosis and therapy
#1942Evaluation method and screening method for sphingosine-1-phosphate 1 (S1P1) receptor agonists
#1943Recombinant AAV-crumbs homologue composition and methods for treating LCA-8 and progressive RP
#1944Activation of TRPV4 ion channel by physical stimuli and critical role for TRPV4 in organ-specific inflammation and itch
#1945Method to generate antibodies to ion channels
#1946Methods of reducing myocardial injury following myocardial infarction
#1947Molecular signature of cancer
#1948Therapeutic TREM-1 peptides
#1949Feline bitter taste receptors and methods
#1950Chimeric antigen receptor and methods of use thereof
#1951Methods of treating cancer by administering a soluble receptor comprising a human Fc domain and the Fri domain from human frizzled receptor
#1952COMPOSITIONS AND METHODS FOR TREATING SMOOTH MUSCLE DYSFUNCTION
#1953In vitro method using hetero-oligomeric T1R1/T1R3 taste receptors to identify umami tastants
#1954Selection vectors and methods of selecting eukaryotic host cells
#1955Mutant channelrhodopsins with altered ion selectivity
#1956COMPOSITION AND VACCINE FOR TREATING LUNG CANCER
#1957COMPOSITION AND VACCINE FOR TREATING PROSTATE CANCER
#1958TUMOR ANTIGEN PEPTIDE
#1959Means and methods for diagnosing and treating multiple sclerosis
#1960High affinity NY-ESO T cell receptors
#1961REGULATION OF SODIUM CHANNELS BY PLUNC PROTEINS
#1962NOGO Receptor Antagonists
#1963Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#1964Methods of treating anaemia
#1965Non-human animals having a humanized cluster of differentiation 47 gene
#1966Modified polynucleotides for the production of proteins
#1967Botulinum neurotoxins with modified light chain specificity and methods for producing same
#1968Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
#1969STEPWISE DIFFERENTIATION OF STEM CELLS FOR THE PRODUCTION OF EUKARYOTIC MEMBRANE PROTEINS
#1970Retinal on bipolar cells-specific artificial promoter
#1971Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody
#1972Therapeutic delivery vesicles
#1973PEPTIDES WITH ENHANCED STABILITY AND THEIR USE IN METHODS FOR TREATING DISEASES
#1974FcRn-specific human antibody and composition for treatment of autoimmune diseases
#1975Compositions and Methods of Altering Cholesterol Levels
#1976Immunity to folate receptors
#1977MESSENGER UNA MOLECULES AND USES THEREOF
#1978Compositions comprising chimeric antigen receptors, T cells comprising the same, and methods of using the same
#1979Methods of treating cancer with antibodies that bind P2X7 receptors
#1980Modified membrane spanning proteins and methods for the preparation and use thereof
#1981Composition comprised of antigen linked to a TNF superfamily ligand
#1982Inhibitors of mitochondrial fission and methods of use thereof
#1983COMPOSITIONS OF HUMANIZED NOTCH FUSION PROTEINS AND METHODS OF TREATMENT
#1984Methods for treating brain cancer using il-13r alpha 2 peptide-based compositions
#1985Disease-associated antigens and methods of use thereof
#1986Therapeutics for the induction of endogenous steroidogenesis and methods associated with their identification
#1987CFTR mRNA compositions and related methods and uses
#1988Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells
#1989Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)
#1990Water soluble G-protein coupled receptor
#1991Implantable prosthetic device comprising a cell expressing a channelrhodopsin
#1992Bis-sulfhydryl macrocyclization systems
#1993MODULATION OF MITOCHONDRIAL CALCIUM UNIPORTER ACTIVITY FOR TREATING AND PREVENTING ARRHYTHMIAS
#1994Methods of using U2-OS cells to identify potential sweet taste modulators
#1995Taste receptor internalization assay
#1996Wnt antagonist and methods of treatment and screening
#1997In vitro production of red blood cells with proteins comprising sortase recognition motifs
#1998Chimeric Antigen Receptors
#1999Methods of Identifying Candidate Compounds of the Human G Protein-Coupled Receptor, GPR50, as Modulators of Body Mass or Adiposity
#2000Effective delivery of large genes by dual AAV vectors
#2001Treatment of Fibrodysplasia Ossificans Progressiva
#2002B-TYPE PLEXIN ANTAGONISTS AND USES THEREOF
#2003Modified polynucleotides for the production of biologics and proteins associated with human disease
#2004Methods of identifying compounds for the treatment of fibrosis by using S1PR5
#2005INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS
#2006Notch pathway inhibition
#2007Composition for delivery of genetic material
#2008T2R taste receptors and genes encoding same
#2009RAPID CLEARANCE OF ANTIGEN COMPLEXES USING NOVEL ANTIBODIES
#2010Methods, uses and compositions of Tie2 agonists
#2011Identification of tumour-associated cell surface antigens for diagnosis and therapy
#2012Bruton's tyrosine kinase as anti-cancer drug target
#2013Depletion of mouse cells for isolation of human cells
#2014Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
#2015Antibodies to MICA and MICB proteins
#2016Stabilized SOS1 peptides
#2017Devices, systems and methods for optogenetic modulation of action potentials in target cells
#2018Channelrhodopsin variants and uses thereof
#2019Inhibitors of TLR signaling by targeting TIR domain interfaces
#2020Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
#2021Use of GPR83 to identify pruritus-related substances
#2022Methods and compositions using a Klotho-FGF23 fusion polypeptide
#2023RHAMM binding peptides
#2024Recombinant polypeptide production
#2025Treating hepatitis B virus infections by administering receptor associated protein (RAP)
#2026Compounds for treating neurodegenerative proteinopathies
#2027Non-hemolytic LLO fusion proteins and methods of utilizing same
#2028Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
#2029Method for augmenting vision in persons suffering from photoreceptor cell degeneration
#2030SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto
#2031Lipopeptides for use in treating liver diseases and cardiovascular diseases
#2032Feline bitter taste receptors and methods
#2033KCNK3 Channel Loss-of-Function Mutants in Familial and Idiopathic Pulmonary Arterial Hypertension
#2034Assay for inhibitors of equilibrative or concentrative nucleoside transporters
#2035Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy
#2036Fusion immunomodulatory proteins and methods for making same
#2037Gene Expression Control DNA Element and Associated Protein
#2038Feline bitter taste receptors and methods
#2039Use of TRPC6 mRNA levels in peripheral blood cells for early detection/diagnosis of senile dementia
#2040Notch inhibition in the prevention of vein graft failure
#2041Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation
#2042Biosensor incorporating protein-immobilized membrane and method of immobilizing protein in biosensor
#2043In vivo production of proteins
#2044Chimeric polypeptides comprising G protein-coupled receptors and VHH antibodies
#2045Enhanced AAV-mediated gene transfer for retinal therapies
#2046TOMM34 peptides and vaccines including the same
#2047Water-soluble trans-membrane proteins and methods for the preparation and use thereof
#2048TMEM120A ion channel modulator
#2049Optogenetic probes for measuring membrane potential
#2050Acid-resistant yeast cell with reduced FPS1 activity and method of producing lactate by using the yeast cell
#2051Methods of treating cholangiocarcinoma
#2052Pro-angiogenic fragments of prominin-1 and uses thereof
#2053Method for selecting agents that bind to transmembrane receptors in a conformationally selective manner
#2054Polypeptide and imaging method
#2055PEPTIDE
#2056Retinal OFF circuit-specific promoter
#2057Compositions and methods for immunotherapy
#2058Humanized or affinity-matured anti Ang-2 antibody and uses thereof
#2059Toll-like receptor 2-agonistic lipopeptides, and method of making the same
#2060NOTCH-BASED FUSION PROTEINS AND USES THEREOF
#2061Soybean ROD1 gene sequences and uses thereof
#2062Angiopoietin-2 specific TIE2 receptor
#2063Phoenixin peptides
#2064T1R taste receptors and genes encoding same
#2065Human Notch Receptor Mutations and Their Use
#2066Antibody to genetic products differentially expressed in tumors and the use thereof
#2067Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same
#2068Method for treating heart disease by inhibiting the Coxsackievirus-Adenovirus Receptor
#2069Materials and Methods for Regulating Whole Body Glucose Homeostasis
#2070PEPTIDIC ANTAGONISTS OF CLASS III SEMAPHORINS/NEUROPILINS COMPLEXES
#2071Nucleic acids encoding a cold- and menthol-sensitive receptor
#2072Reactivation of Axon Growth and Recovery in Chronic Spinal Cord Injury
#2073Engineered receptors and their use
#2074COMPOSITIONS AND METHODS FOR TREATING ANTIPHOSPHOLIPID SYNDROME
#2075Template-fixed peptidomimetics with CXCR7 modulating activity
#2076Method and compositions for cellular immunotherapy
#2077METHODS AND COMPOSITIONS FOR IMPROVING SUGAR TRANSPORT, MIXED SUGAR FERMENTATION, AND PRODUCTION OF BIOFUELS
#2078Agents that modulate immune cell activation and methods of use thereof
#2079T1R taste receptors and genes encoding same
#2080Methods and compositions for modulating Toso activity
#2081cDNA-derived nucleic acids encoding red-shifted channelrhodopsins
#2082IMMUNOGENIC VACCINE
#2083Development of HBV-and/or HDV-susceptible cells, cell lines and non-human animals
#2084MEDICAL TREATMENT USE OF CELL-MEMBRANE-PERMEABLE FIBROBLAST GROWTH FACTOR
#2085METHODS AND COMPOSITIONS FOR MODULATING NOTCH ACTIVITY
#2086Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
#2087Compositions and Methods for the Diagnosis of Retinal Neovascularization
#2088PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT INCLUDING FUSION PROTEIN
#2089COMPOSITIONS AND METHODS OF MODULATING AN IMMUNE RESPONSE
#2090BIOMARKER FOR USE IN TREATING ANEMIA
#2091Method for detecting lung squamous cell carcinoma
#2092Sweet taste receptor chimeric proteins and use thereof
#2093Antibodies to non-functional P2X7 receptor
#2094DC-STAMP antibodies
#2095DETECTION AND TREATMENT OF NON-DERMAL FIBROSIS
#2096Method for identifying compounds that modulate a T2R taste receptor
#2097Compositions and methods for enhanced gene expression in cone cells
#2098Chimeric nucleic acid molecule with non-AUG translation initiation sequences
#2099NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM
#2100Methods and Compositions for Detecting Botulinum Neurotoxin